Literature DB >> 18600859

Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture.

D K Robinson1, K W Memmert.   

Abstract

A clonal derivative of a transfectant of the SP2/O myeloma cell line producing a chimeric monoclonal antibody was maintained in steady-state, continuous culture at dilution rates ranging from 0.21 to 1.04 day(-1). The steady-state values for nonviable and total cell concentrations increased as the dilution rate decreased, while the viable cell concentration was roughly independent of the dilution rate. At steady state, the specific growth rate increased and the specific death rate decreased as the dilution rate increased. The maximum specific growth rate was 1.15 day(-1). Antibody production was growth associated and the specific rate of antibody production increased linearly as the specific growth rate increased.

Entities:  

Year:  1991        PMID: 18600859     DOI: 10.1002/bit.260380903

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  13 in total

1.  Avoiding rapid growth at high cell densities: a potentially important optimisation criterion for hybridoma cultures.

Authors:  L K Nielsen; W Niloperbowo; S Reid; P F Greenfield
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.

Authors:  M al-Rubeai; A N Emery; S Chalder; D C Jan
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Foreign protein expression from S phase specific promoters in continuous cultures of recombinant CHO cells.

Authors:  G G Banik; P W Todd; D S Kompala
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Increasing batch-to-batch reproducibility of CHO cultures by robust open-loop control.

Authors:  M Aehle; A Kuprijanov; S Schaepe; R Simutis; A Lübbert
Journal:  Cytotechnology       Date:  2010-11-06       Impact factor: 2.058

5.  Expression of recombinant antibody and secreted alkaline phosphatase in mammalian cells. Influence of cell line and culture system upon production kinetics.

Authors:  A J Racher; J L Moreira; P M Alves; M Wirth; U H Weidle; H Hauser; M J Carrondo; J B Griffiths
Journal:  Appl Microbiol Biotechnol       Date:  1994-02       Impact factor: 4.813

6.  Cultural and physiological factors affecting expression of recombinant proteins.

Authors:  J B Griffiths; A J Racher
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

7.  Proliferation control of mammalian cells by the tumor suppressor IRF-1.

Authors:  M Köster; S Kirchhoff; F Schaper; H Hauser
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

8.  Physiology of myeloma cells grown in glucose-limited chemostat cultures.

Authors:  P R Levering; J A van Heijst; C M Sünnen
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

9.  Engineering Chinese hamster ovary (CHO) cells to achieve an inverse growth - associated production of a foreign protein, beta-galactosidase.

Authors:  F W Lee; C B Elias; P Todd; D S Kompala
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

10.  Effect of feed rate on growth rate and antibody production in the fed-batch culture of murine hybridoma cells.

Authors:  J D Jang; J P Barford
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.